Together, these findings suggest that MASLD in T1D cannot be fully explained by insulin resistance alone and is likely to result from a combination of unique factors, including insulin delivery patterns, glucagon dysregulation, autoimmune effects, and ectopic fat metabolism. This evidence concerns the gene GCG and Insulin resistance.